Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2006

01-02-2006 | Preclinical study

Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling

Authors: Steven J. Van Laere, Gert G. Van den Eynden, Ilse Van der Auwera, Melanie Vandenberghe, Peter van Dam, Eric A. Van Marck, Kenneth L. van Golen, Peter B. Vermeulen, Luc Y. Dirix

Published in: Breast Cancer Research and Treatment | Issue 3/2006

Login to get access
Metadata
Title
Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling
Authors
Steven J. Van Laere
Gert G. Van den Eynden
Ilse Van der Auwera
Melanie Vandenberghe
Peter van Dam
Eric A. Van Marck
Kenneth L. van Golen
Peter B. Vermeulen
Luc Y. Dirix
Publication date
01-02-2006
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2006
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-005-9015-9

Other articles of this Issue 3/2006

Breast Cancer Research and Treatment 3/2006 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine